MEK

nwamba # Aha ngwaahịa Nkọwa
CPDB0157 BI-847325 BI-847325 bụ nhọrọ abụọ MEK / Aurora kinase inhibitor nwere ụkpụrụ IC50 nke 3, 25, 15, 25, na 4 nM maka X. laevis Aurora B, mmadụ Aurora A na Aurora C, na mmadụ MEK1 na MEK2, n'otu n'otu. Ọ nwere ike igbochi uto na nlanarị nke ahịrị mkpụrụ ndụ melanoma na-adịghị ahụkebe na ọgwụ na-eguzogide ọgwụ, na-ebelata okwu MEK na Mcl-1 ebe ọ na-abawanye okwu pro-apoptotic protein Bim. Na 70 mg / kg, BI-847325 na-ebute apoptosis na ọgwụgwọ-naive na ọgwụ na-eguzogide xenografted melanoma na vivo.
nke

Kpọtụrụ anyị

Ajuju

Akụkọ kacha ọhụrụ

  • Usoro 7 kachasị na nyocha ọgwụ na 2018

    Usoro 7 kacha elu na nyocha ọgwụ m...

    N'ịbụ ndị nọ n'okpuru nrụgide na-arịwanye elu mgbe niile ịsọ mpi na gburugburu ebe obibi akụ na ụba na nkà na ụzụ siri ike, ụlọ ọrụ ọgwụ na biotech ga-anọgide na-emepe emepe na mmemme R&D ha iji nọgide na-aga n'ihu ...

  • ARS-1620: Onye mmechi ọhụrụ na-ekwe nkwa maka ọrịa cancer KRAS-mutant

    ARS-1620: ihe mgbochi ọhụrụ na-ekwe nkwa maka K…

    Dị ka otu nnyocha e bipụtara na Cell si kwuo, ndị nchọpụta ewepụtala ihe mgbochi kpọmkwem maka KRASG12C nke a na-akpọ ARS-1602 nke na-eme ka ụbụrụ tumor regression na ụmụ oke. "Ọmụmụ ihe a na-enye na vivo ihe akaebe na mutant KRAS nwere ike ịbụ ...

  • AstraZeneca na-enweta nkwalite nchịkwa maka ọgwụ oncology

    AstraZeneca na-enweta nkwalite nchịkwa maka ...

    AstraZeneca nwetara nkwalite okpukpu abụọ maka pọtụfoliyo oncology ya na Tuesday, mgbe ndị na-ahụ maka US na European nabatara ntinye iwu maka ọgwụ ya, nzọụkwụ mbụ iji nweta nkwado maka ọgwụ ndị a. ...

Mkparịta ụka WhatsApp n'ịntanetị!